Home World News United States News Historic ‘living drug’ gets go-ahead
United States News

Historic ‘living drug’ gets go-ahead

Share
historic living drug gets go ahead
Share
KymriahImage copyright Novartis

The US has approved the first treatment to redesign a patient’s own immune system so it attacks cancer.

The regulator – the US Food and Drug Administration – said its decision was a “historic” moment and medicine was now “entering a new frontier”.

The company Novartis is charging $475,000 (£367,000) for the therapy, which leaves 83% of people free of a type of blood cancer.

Doctors in the UK said the announcement was an exciting step forward.

The “living drug” is tailor-made to each patient, unlike conventional therapies such as surgery or chemotherapy.

It is called CAR-T and is made by extracting white blood cells from the patient’s blood.

The cells are then genetically reprogrammed to seek out and kill cancer.

The cancer-killers are then put back inside the patient and once they find their target they multiply.

‘Enormously exciting’

Dr Scott Gottlieb, from the FDA, said: “We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer.

“New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to treat and even cure many intractable illnesses.”

The therapy, which will be marketed as Kymriah, works against acute lymphoblastic leukaemia.

Most patients respond to normal therapy and Kymriah has been approved for when those treatments fail.

Dr Stephan Grupp, who treated the first child with CAR-T at the Children’s Hospital of Philadelphia, said the new approach was “enormously exciting”.

“We’ve never seen anything like this before,” he added.

That first patient had been near to death, but has now been cancer-free for more than five years.

Out of 63 patients treated with CAR-T therapy, 83% were in complete remission within three months and long-term data is still being collected.

However, the therapy is not without risks.

It can cause potentially life-threatening cytokine release syndrome from the rapid proliferation of the CAR-T cells in the body. This can be controlled with drugs.

New era

But the potential of CAR-T technology goes beyond one type of cancer.

Dr David Maloney, medical director of cellular immunotherapy at the Fred Hutchinson Cancer Research Center, said the FDA’s decision was a “milestone”.

He added: “We believe this is just the first of what will soon be many new immunotherapy-based treatments for a variety of cancers.

CAR-T technology has shown most promise against different blood-based cancers.

However, it has struggled against “solid tumours” such as lung cancer or melanoma.

Dr Prakash Satwani, a paediatric oncologist at Columbia University Medical, said: “The results haven’t been that great when you compare it with acute lymphoblastic leukaemia, but I’m sure the technology will get better in the near future.”

Boosting the immune system is already a cornerstone of modern cancer treatment.

A range of drugs that “take the brakes off” the immune system to allow it to attack cancer more freely have already been adopted around the world.

CAR-T technology, which goes a step further and redesigns the immune system, is at a much earlier stage.

Prof Peter Johnson, the chief clinician at the charity Cancer Research UK, said: “The first genetically modified cell therapy to be approved by the FDA is an exciting step forward.

“We still have a lot to learn about how to use it safely and who might benefit from it, so it is important to recognise this is just a first step.”

Follow James on Twitter.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts

Related Articles
Times Gavin Newsom Proved He's Better At Nicknames Than 'Tiny Hands' Trump
PoliticsUnited States News

Gavin Newsom’s Nickname Game: Outshining Trump’s ‘Tiny Hands’ Insults

In his X taunts, Gavin Newsom has used nicknames for MAGA notables...

These Are By Far The Weirdest Marriages In Mar-A-Lago
PoliticsUnited States News

Odd Couples at Mar-a-Lago: A Peek Behind the Velvet Rope

The parents of Barron Trump's bestie and a disgraced congressman and his...

The Possible Reason For Barron Trump's Disappearance Is Darker Than Expected
United States NewsPolitics

When a Son Fades from View: Why Barron Trump’s Quietness Feels Complicated

It's odd that first son Barron Trump hasn't been attending any public...

Trump Finally Gets A Bleach Touch-Up After Neglecting His Near-Gray Color For Weeks
PoliticsUnited States News

Trump’s Hair Drama: From Ashy Gray to Bleached Blond Again

Donald Trump has been accused of letting his hair go gray to...